Summary:
- Biogen and Stoke Therapeutics, two leading pharmaceutical companies, presented new data at the 54th Child Neurology Society Annual Meeting.
- The data focused on the development of potential treatments for genetic disorders affecting the nervous system, particularly in children.
- The research showcases the companies' commitment to advancing scientific understanding and finding innovative solutions to address these complex medical challenges.